EXEL- Exelixis, Inc.
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 11 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $100.89M | - | |
| Dir | 1.55M | $79.76M | - | |
| Dir | 1.19M | $61.07M | - | |
| CFO | 1.12M | $57.37M | - | |
| VP | 594.7K | $30.54M | -43,451 |
Activity
Buys and sells only
Transactions
10 filings · page 7
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 27, 2023 | Johnson David Edward83 | Director | Buy | 120,409 | $21.61 | $2,602,038.49 | +15.2% | +1.6% | +68.7% | |
| Aug 30, 2023 | Aftab Dana | Cso/ EVP Disc &Trans Research | Sell | 4,600 | $22.47 | $103,362.00 | -1.1% | -6.4% | +15.6% | |
| Aug 4, 2023 | Senner Christopher J. | EVP And CFO | Sale+OE | 120,000 | $20.60 | $2,471,400.00 | -9.5% | -0.7% | +19.2% | |
| Aug 3, 2023 | Haley Patrick J.56 | EVP, Commercial | Sell | 30,553 | $20.67 | $631,530.51 | -9.7% | +1.3% | +16.4% | |
| Aug 1, 2023 | Hessekiel Jeffrey54 | EVP, General Counsel &Sec | Sale+OE | 55,710 | $19.63 | $1,093,587.30 | -8.9% | +3.1% | +19.5% | |
| Apr 5, 2023 | Hessekiel Jeffrey54 | EVP, General Counsel &Sec | Sale+OE | 38,930 | $20.01 | $778,989.30 | -6.3% | -4.3% | +18.1% | |
| Mar 10, 2023 | Wyszomierski Jack L | Director | Sale+OE | 15,300 | $16.61 | $254,133.00 | -4.6% | +16.0% | +33.2% | |
| Mar 1, 2023 | Hessekiel Jeffrey54 | EVP, General Counsel &Sec | Sale+OE | 77,860 | $17.13 | $1,333,741.80 | -12.9% | +8.8% | +25.4% | |
| Feb 28, 2023 | Aftab Dana | Cso/ EVP Disc &Trans Research | Sale+OE | 82,500 | $17.50 | $1,443,750.00 | -10.5% | +11.3% | +28.3% | |
| Feb 21, 2023 | Garber Alan M50 | Director | Sale+OE | 40,000 | $17.49 | $699,600.00 | -56.0% | +13.3% | +18.7% |